Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$891M |
| 2 |
Union Pacific
UNP
|
+$622M |
| 3 |
Salesforce
CRM
|
+$418M |
| 4 |
Edwards Lifesciences
EW
|
+$405M |
| 5 |
lululemon athletica
LULU
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$680M |
| 2 |
Texas Instruments
TXN
|
+$585M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$558M |
| 5 |
Parker-Hannifin
PH
|
+$556M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.29% |
| 2 | Healthcare | 17.78% |
| 3 | Consumer Discretionary | 17.1% |
| 4 | Financials | 12.69% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Chemed
CHE
$6.84B
| – | – |
-5,682
| Closed | -$1.82M |
|
652
Coherus Oncology
CHRS
$218M
| – | – |
-26,840
| Closed | -$443K |
|
653
Ciena
CIEN
$53.6B
| – | – |
-56,591
| Closed | -$1.77M |
|
|
CIM
654
Chimera Investment
CIM
$963M
| – | – |
-198,143
| Closed | -$10.8M |
|
655
Core Laboratories
CLB
$567M
| – | – |
-145,795
| Closed | -$16.9M |
|
|
CLDT
656
Chatham Lodging
CLDT
$637M
| – | – |
-40,624
| Closed | -$849K |
|
657
Cogent Biosciences
COGT
$6.02B
| – | – |
-222,508
| Closed | -$9.17M |
|
658
ConocoPhillips
COP
$157B
| – | – |
-3,044
| Closed | -$236K |
|
659
Capri Holdings
CPRI
$1.53B
| – | – |
-9,134
| Closed | -$626K |
|
660
Carpenter Technology
CRS
$23.6B
| – | – |
-6,722
| Closed | -$396K |
|
661
CRISPR Therapeutics
CRSP
$5.58B
| – | – |
-540,887
| Closed | -$24M |
|
662
Deckers Outdoor
DECK
$12B
| – | – |
-34,032
| Closed | -$673K |
|
663
Dollar Tree
DLTR
$24.1B
| – | – |
-252,197
| Closed | -$20.6M |
|
664
DXC Technology
DXC
$1.79B
| – | – |
-398,740
| Closed | -$37.3M |
|
665
Brinker International
EAT
$9.87B
| – | – |
-31,003
| Closed | -$1.45M |
|
|
EB
666
DELISTED
Eventbrite
EB
| – | – |
-98,115
| Closed | -$3.73M |
|
667
Encompass Health
EHC
$11.9B
| – | – |
-11,182
| Closed | -$693K |
|
668
Eastman Chemical
EMN
$8.35B
| – | – |
-65,958
| Closed | -$6.31M |
|
669
Eaton
ETN
$156B
| – | – |
-144,458
| Closed | -$12.5M |
|
670
Etsy
ETSY
$7.67B
| – | – |
-13,007
| Closed | -$668K |
|
671
FedEx
FDX
$78.3B
| – | – |
-389,474
| Closed | -$93.8M |
|
672
Flex
FLEX
$40.8B
| – | – |
-8,829,693
| Closed | -$87.3M |
|
673
CALL
Gilead Sciences
GILD
$181B
| – | – |
-360,000
| Closed | -$27.8M |
|
|
GMS
674
DELISTED
GMS Inc
GMS
| – | – |
-24,429
| Closed | -$567K |
|
|
B
675
Barrick Mining
B
$75.1B
| – | – |
-14,157
| Closed | -$157K |
|
Similar funds
Jennison Associates's Q4 2018 Portfolio in Review
As of Q4 2018, Jennison Associates held 753 positions worth $89.4B, down 18% from $109B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q4 2018 filing shows 95 new, 255 increased, 283 reduced and 113 closed positions. Its largest new stake was lululemon athletica: 2,588,881 shares worth $315M. The largest sale was Caterpillar, an estimated $680M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jennison Associates's largest Q4 2018 buy was lululemon athletica: 2,588,881 shares worth $315M.
- Jennison Associates added most to Merck in Q4 2018, an estimated $891M increase.
- Jennison Associates's biggest Q4 2018 reduction was Caterpillar, cutting an estimated $680M.
- Jennison Associates fully exited Tiffany & Co. in Q4 2018, selling an estimated $151M.
- Jennison Associates's ten largest holdings make up 30% of its $89.4B portfolio in Q4 2018.
- Jennison Associates opened 95 new positions and closed 113 in Q4 2018.
- Jennison Associates's portfolio value fell 18% quarter-over-quarter to $89.4B.
Based on Jennison Associates's 13F filing for Q4 2018, filed 6 Feb 2019.